Back
Innate Pharma SA Vs. Enerpac Tool Group Industry Stock Comparison
Buy
52
IPHA
Innate Pharma SA
Last Price:
$2.03
Seasonality Move:
-1.32%
Buy
61
EPAC
Enerpac Tool Group
Last Price:
$44.80
Seasonality Move:
1.24%
Buy
52
Innate Pharma SA (IPHA)
is a Buy
Is Innate Pharma SA a Buy, Sell or Hold?
-
The current Innate Pharma SA [IPHA] share price is $1.98. The Score for IPHA is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
IPHA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Enerpac Tool Group (EPAC)
is a Buy
Is Enerpac Tool Group a Buy, Sell or Hold?
-
The current Enerpac Tool Group [EPAC] share price is $44.80. The Score for EPAC is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
EPAC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $1.98Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IPHA is experiencing slight selling pressure.
EPAC Stock Price Chart
What is Enerpac Tool Group's stock price today?
-
The Enerpac Tool Group share price today is $44.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EPAC is experiencing selling pressure, which indicates risk of future bearish movement.
IPHA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 48.62 | Sell |
Chaikin Money Flow: | -2947 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.95 - 2.17) | Sell |
Bollinger Bands (100): | (1.64 - 2.14) | Buy |
EPAC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 12.33 | Buy |
Relative Strength Index (14 RSI): | 50.58 | Buy |
Chaikin Money Flow: | -127153 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.41 - 45.97) | Buy |
Bollinger Bands (100): | (42.89 - 48.03) | Sell |
IPHA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.97 | Buy |
20-day SMA: | 2.01 | Sell |
50-day SMA: | 1.96 | Buy |
200-day SMA: | 2.03 | Sell |
8-day EMA: | 1.96 | Buy |
20-day EMA: | 2 | Sell |
50-day EMA: | 1.98 | Sell |
200-day EMA: | 2.07 | Sell |
EPAC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.51 | Buy |
20-day SMA: | 44.41 | Buy |
50-day SMA: | 44.79 | Buy |
200-day SMA: | 42.95 | Buy |
8-day EMA: | 37.31 | Buy |
20-day EMA: | 22.59 | Buy |
50-day EMA: | 10.92 | Buy |
200-day EMA: | 3.02 | Buy |
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Enerpac Tool Group Earnings Growth & EPAC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.09 per share, an increase this year of $0.03 per share, and an increase next year of $0.27 per share.
Innate Pharma SA Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Enerpac Tool Group Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |